Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Extraordinary Conceptions Launches Mexico Location


“We have gone to great lengths to create surrogacy and egg donation programs with proven IVF centers and reproductive attorneys for your safety and assurance. And the best part is that all U.S. laws and our strict protocol will be followed in conjunction with the legalities in Mexico.”

Extraordinary Conceptions, a premier surrogacy and egg donation agency, is proud to announce the opening of its Mexico office to help even more intended parents realize their dream of starting a family. The Puerto Vallarta location is the agency’s most cost-effective option in North America. It is part of Extraordinary Conceptions’ commitment to providing affordable options to clients who may be dealing with financial challenges during these unprecedented times.

Based in San Diego, Extraordinary Conceptions has helped clients from around the world find their ideal egg donors and gestational carriers since 2005. During that time, the agency has built an excellent reputation for guiding future families through egg donation or surrogacy with warmth and compassion. As with all Extraordinary Conceptions locations, the Mexico office will be staffed with a knowledgeable, empathetic team. It has partnered with two of the top IVF clinics in the country. The goal is to give all intended parents a comfortable, supportive fertility journey.

“We are so excited to be able to offer choices in Mexico to our intended parents,” says Mario Caballero, CEO of Extraordinary Conceptions. “We have gone to great lengths to create surrogacy and egg donation programs with proven IVF centers and reproductive attorneys for your safety and assurance. And the best part is that all U.S. laws and our strict protocol will be followed in conjunction with the legalities in Mexico.”

Applications for future parents, egg donors and surrogates are available on the Extraordinary Conceptions website. For more information, or to learn more about the Mexico location,

visit https://www.extraconceptions.com.

About Extraordinary Conceptions: Extraordinary Conceptions is a premier agency that’s helped thousands of Intended Parents achieve their dreams of building a family through surrogacy and egg donation. As the leading international agency, Extraordinary Conceptions guides clients to discover their perfect egg donor and Gestational Carrier to help fulfill their dreams of parenthood. Extraordinary Conceptions’ commitment, skills and compassion are unparalleled by other agencies in the fertility field. For more information, visit https://www.extraconceptions.com.

Share article on social media or email:

Post-Brexit European Clinical Supply Solutions to be Discussed by Catalent at Upcoming Forum


Catalent, a global leader in clinical supply services, today announced that Paul Ingram, Ph.D., Global Director, Strategic Development and Innovation, will present at the upcoming conference, ‘Clinical Trial Supply Forum’, which takes place virtually on Aug. 25-26, 2020.

Dr. Ingram’s presentation, titled, “Beyond Brexit: What Now for Clinical Supply Services Across Europe?”, will take place on Wednesday, Aug. 26, at 2:40 p.m. BST. While the U.K. is no longer a member of the European Union, it remains part of the EU’s Single Market and Customs Union until the end of the transition period, on December 31, 2020. Dr. Ingram’s presentation will explore the potential impact of the U.K. no longer participating in the EU’s Single Market and Customs Union on the clinical supply chain, and discuss strategic options for managing clinical supplies across the U.K. and continental Europe from the beginning of 2021 and beyond.

During his 25-year career, Dr. Ingram’s work has focused on medical devices and pharmaceutical research and development. He has over 15 years of experience in clinical supplies, working in both Phase 1 unit manufacturing suites and trial supplies service companies, including Quintiles (Aptuit), Fisher Clinical and, since 2011, Catalent. Dr. Ingram obtained his doctorate in pharmaceutical development from Strathclyde University in Glasgow, U.K.

For further information, please visit: https://www.clinical.catalent.com/events/clinical-trial-supply-online-2020/

About Catalent Clinical Supply Services

Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries, Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,500 people, including approximately 2,400 scientists and technicians, at more than 40 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Conductiv™ Introduces Diversity Initiative, Helping Health Systems Increase Spending with Minority-Owned Suppliers to Stimulate Economy and Improve Population Health


Conductiv™, the leading third-party spend optimization solutions provider, announced today an initiative to help healthcare providers better identify and increase their spend with local and minority-owned suppliers.

As local, minority-owned suppliers have struggled with the economic impact of COVID-19, and the public advocates for businesses that promote greater equality, Conductiv’s latest enhancement offers diverse suppliers an effective and proven way to grow their businesses, while enabling providers to encourage and promote diversity with their third-party service providers.

“Healthcare providers are looking to support a more diverse and inclusive roster of suppliers—including community-led minority-, women- and veteran-owned businesses—but it can often be difficult to identify diverse suppliers with capabilities needed within the healthcare industry,” said Conductiv CEO Chris Gormley. “Recognizing both the importance and need for national change in this moment, we immediately deployed a team of developers to create technology enhancements that enable Conductiv’s members to increase their percentage of spend with diverse and local suppliers. Studies have shown that population health and economic performance are correlated and hold influence over social and environmental outcomes.”

Conductiv will anchor this initiative by adding diversity analytics to its integrated third-party services optimization suite—allowing for immediate visibility of Tier 1 and Tier 2 local and minority-owned supplier spending and new suppliers. Customers will have the ability to precisely measure their diverse supplier spending and efficiently evaluate and activate new contracts with carefully vetted local, minority-owned suppliers from one platform.

Conductiv will also add local and regional GPO contracts with vetted diverse suppliers and illuminate diverse supplier GPO contracting opportunities based on a healthcare organization’s historic spend. For minority-owned suppliers, working with Conductiv Contracts provides an opportunity to grow their businesses with regional and national healthcare providers. A member advisory committee will guide these collective efforts and investments.

“We’re committed to helping healthcare supply chains increase their diversity and inclusion efforts by connecting them to high-quality minority-owned suppliers,” Gormley added. “Our members have indicated their challenges in differentiating diverse spend and finding qualified diverse suppliers. To solve these challenges, our team is building off Conductiv’s category-defining integrated purchased services optimization suite and strengthening our data sources to ensure this is a simple and advantageous feature for both healthcare providers and diverse suppliers.”

For more information, please visit Conductiv.com.

About Conductiv

ConductivTM, formerly Medpricer, empowers supply chains to optimize their third-party services. As the only end-to-end third-party lifecycle improvement company, ConductivTM shares its strategic sourcing expertise and category best practices with multiple industries including healthcare, hospitality, government, real estate, transportation and education. The company has led more than 700 bids for more than 120 organizations, exceeding $4 billion in contracted value. Member projects have generated $800 million of documented savings or an average savings value of 24% to date. To learn how supply chains are transforming their savings strategy, visit Conductiv.com.

###

Share article on social media or email:

Free the Doc Cam In Your Laptop With IPEVO’s Mirror-Cam


IPEVO Mirror-Cam

One of the biggest hurdles they faced was real-time interaction and feedback. Mirror-Cam exists to eliminate that inconvenience, all in an adjustable and compact design that users can take wherever they go.

IPEVO, the key leader in visual communication technology has just announced the release of their newest product, Mirror-Cam.

Due to the rapid increase in remote learning, students and teachers alike are constantly searching for a solution to replicate their original learning environment. One of the biggest hurdles they faced was real-time interaction and feedback. Mirror-Cam exists to eliminate that inconvenience, all in an adjustable and compact design that users can take wherever they go.

Simple but intuitive, the mirror inside Mirror-Cam allows users to transform their laptop webcams to create a “document camera effect.” By redirecting the laptop webcam’s field of view to the keyboard area, anything that happens over the keyboard also happens on the laptop screen.

Students are then able to utilize the overhead showcase space to take notes, create sketches, solve problems, do read alouds, and many other things, all whilst receiving live feedback. This lets students take the lead of their own learning while giving teachers and parents the flexibility and convenience to make the most out of the learning process.

Users may also take advantage of IPEVO’s Visualizer software to capture the optimal image. Functions ranging from simple controls such as rotating and enlarging images to taking photos, recording videos, and keystone image correction are just some of what Visualizer can offer.

The Mirror-Cam is now available in packs of 6 for $39.99 and can be purchased through either IPEVO’s Online Store or Amazon.

For more information about the Mirror-Cam, visit: https://www.ipevo.com/products/mirror-cam

Based in Sunnyvale, CA, IPEVO is an EdTech company that makes and sells versatile visual communication tools. Designed with users in mind, IPEVO offers simple, affordable software, document cameras, and communication tools to help people create, teach, learn, inspire, and collaborate effortlessly and efficiently in an interconnected world.

Share article on social media or email:

mPulse Mobile Announces Closing of Series C Funding of more than $16 Million, Led by Optum Ventures


mPulse Mobile logo

“We believe mPulse’s innovative approach to consumer engagement can play a key role in improving health outcomes and lowering the total cost of care.”

mPulse Mobile, a leader in Conversational Artificial Intelligence (AI) solutions for the healthcare industry, today announced more than $16 million in funding. The round was led by Optum Ventures and includes existing investors HLM Venture Partners, OCA Ventures, SJF Ventures, Echo Health Ventures and Rincon Ventures.

Powering more than 300 million personalized, automated consumer healthcare conversations annually, mPulse Mobile’s solutions help consumers and healthcare organizations achieve better health outcomes by increasing engagement and improving communication through meaningful, tailored conversations. mPulse combines behavioral science, artificial intelligence and an enterprise-grade platform to assist healthcare organizations guide consumers to adopt healthy behaviors.

mPulse Mobile has more than a decade of healthcare consumer engagement experience, serving more than 100 healthcare organizations. The Series C investment will help mPulse Mobile further enhance solutions that deliver positive consumer experiences on behalf of its customers.

“We are excited to have the support of Optum Ventures and all of our current investors as we execute on our strategic roadmap to improve health outcomes for consumers and our customers through improved communications,” said Chris Nicholson, CEO of mPulse Mobile. “This new investment recognizes that scale and solution performance are key factors in successfully engaging consumers in their healthcare, and we will use it to expand our consumer conversational AI capabilities, enhance our client engagement analytics platform and expand our engagement solutions across healthcare verticals.”

“mPulse Mobile enables valuable connections between healthcare organizations and consumers, while addressing a significant market need for better experiences,” said Laura Veroneau, Partner, Optum Ventures. “We believe mPulse’s innovative approach to consumer engagement can play a key role in improving health outcomes and lowering the total cost of care.”

About mPulse Mobile

mPulse Mobile, the leader in Conversational AI solutions for the healthcare industry, drives improved health outcomes and business efficiencies by engaging individuals with tailored and meaningful dialogue. mPulse Mobile combines behavioral science, analytics and industry expertise that helps healthcare organizations activate their consumers to adopt healthy behaviors. With over a decade of experience, 100+ healthcare customers and more than 300 million conversations annually, mPulse Mobile has the data, the expertise and the solutions to drive healthy behavior change. For more information, please visit http://www.mpulsemobile.com

About Optum Ventures

Optum Ventures is the independent venture fund of Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone, and part of the UnitedHealth Group. Optum Ventures invests in digital health companies that use data and insights to help improve consumers’ access to health care services and how care is delivered and paid for, and that make the health care system more reliable and easier to navigate. For more information, please visit http://www.optumventures.com.

About HLM Venture Partners

HLM Venture Partners is a leading venture capital firm and one of the nation’s oldest and most experienced in the tech-enabled healthcare services, healthcare information technology, and medical device and diagnostics sectors. Seeking dynamic, emerging-growth companies, HLM invests in the industry’s most innovative companies, including Phreesia, Teladoc, AbleTo, Regroup Therapy, Nordic Consulting, meQuilibrium and ClearDATA. http://www.hlmvp.com

About OCA Ventures

OCA Ventures is an early stage (Seed, Series A, and Series B) venture capital firm focused on equity investments in companies with dramatic growth potential, primarily in technology and highly-scalable services businesses. OCA invests in many industries, with a preference for technology, financial services, cyber security and healthcare technology. Founded in 1999, the firm is investing out of its fourth fund in companies spread throughout the United States. Learn more at http://www.ocaventures.com

About SJF Ventures

SJF Ventures invests in high-growth companies creating a healthier, smarter and cleaner future. Its mission is to catalyze the development of highly successful businesses driving lasting, positive changes. We are experienced venture capital investors who have been at the forefront of impact investing since 1999. We are passionate about generating extraordinary results, creating positive changes, and partnering with visionaries who combine these two. Our team has invested in over 70 companies during the last 21 years, bringing time-tested perspective and expertise to partnerships with entrepreneurs. For more information, visit http://www.sjfventures.com

About Echo Health Ventures

Echo Health Ventures invests to build and grow great health care companies. Echo Health Ventures seeks to drive systemic health care transformation through hands-on, purpose-driven strategic venture capital and growth equity investing. As a strategic collaboration of Cambia Health Solutions and Mosaic Health Solutions, Echo Health Ventures works closely with its parent entities to catalyze the development of its portfolio companies and accelerate their innovations to scale nationally. For more information, please visit http://www.EchoHealthVentures.com

About Rincon Ventures

Rincon Venture Partners, as well as its successor firm Bonfire Ventures, is an LA-based seed-stage venture capital firm that invests exclusively in B2B software businesses, and typically leads or co-leads a startup’s first priced round. We back extraordinary founders who are seeking to build world-class market leaders, and aspire to serve as those founders’ most trusted advisors. Investments made by the firm’s founders include The Trade Desk (IPO), Burstly (acquired by Apple), Edgecast (acquired by Verizon), Datapop (acquired by Criteo), MessageLabs (acquired by Symantec), Orbitera and Bitium (each acquired by Google), EmailAge (Acquired by LexisNexis), TaxJar, ChowNow, Rainforest QA, Invoca, Honk and others. For more information visit http://www.bonfirevc.com

Share article on social media or email:

Blooming Life Possibilities Launches Digital Action Program for Late Bloomers


“I created a program that picked up where the self-help books I was reading left off,” Kossoff explained.

Blooming Life Possibilities today announced the recent launch of its newest digital product: The Transformation Action Program by Laura Kossoff (https://bloominglifepossibilities.com/transformation-action). Kossoff created this program after a decades-long search for her own authentic path to help others thrive as late bloomers or for anyone looking to start a new life chapter.

As many people are rethinking their lives, Kossoff believes this is an exceptional time to focus on creating an intentional and meaningful life. The Blooming Life Transformation Action Program provides tools for identifying your dreams and goals, creating a personalized action plan and overcoming internal and external obstacles.

The program is comprised of five parts, the first of which is a manifesting challenge webinar (running time: 18 minutes). Free, immediate access is available at https://bloominglifepossibilities.com/manifesting-challenge. In the webinar, Kossoff includes examples of successful late bloomers and a powerful exercise to clarify your dreams. Parts 2 through 5 are detailed blueprints on manifesting, achieving your goals, the stages of change and overcoming procrastination. Kossoff includes up-to-date research in an easy-to-understand layout, with stories and personal examples.

Also provided are five action worksheets (PDFs): Clarifying Your Dreams, Achieving Your Goals, Reaching Your Dreams, an Overcoming Procrastination Inventory and a 30-Day Manifesting Journal. To celebrate the launch, Kossoff is offering a complimentary phone consultation with her with any purchase through September 15th.

The Transformation Action Program is for anyone searching for a life of meaning, joy and abundance, looking to wake up each day with a sense of purpose and excitement.

“I created a program that picked up where the self-help books I was reading left off,” Kossoff explained.

Written in a warm, accessible style, The Transformation Action Program is an essential guide for finding your path at any stage of life, proving that when it comes to fulfilling your dreams, it’s never too late.

Share article on social media or email:

Healthcare Management Solutions, LLC, (HMS) Donates $1,800 to Local Senior Center in Honor of the Company’s 18th Anniversary


Donna Alley the Assistant Executive Director/CFO of Marion County Senior Center, Debbie Harvey the Executive Director of Marion County Senior Center, and Leah Heimbach the President of HMS

“No senior should have to worry about falling through cracks in the system, especially when it comes to their nutrition and health. The Home-Delivered Meals program in Marion County does an excellent job of efficiently getting seniors the food they need.” -Leah Heimbach, president & owner of HMS

Healthcare Management Solutions, LLC (HMS), a leading healthcare and IT consulting company, donated $1,800 to the Marion County Senior Citizens, Inc., to help support the Home-Delivered Meals Program that serves seniors throughout Marion County, West Virginia, via the Marion County Senior Center in Fairmont. The $1,800 donation from HMS will cover the cost of 300 meals for Marion County seniors.

“Protecting seniors and other vulnerable populations is at the core of our mission,” said Leah Heimbach, president and owner of HMS. “No senior should have to worry about falling through cracks in the system, especially when it comes to their nutrition and health. The Home-Delivered Meals program here in Marion County does an excellent job of efficiently getting seniors the food they need.”

Home-Delivered Meals delivers meals to persons 60 years and older who are unable to prepare meals for themselves.

Since launching the company 18 years ago on August 8, Heimbach and her team at HMS have focused on serving federal and state agencies that protect vulnerable people, helping to ensure that seniors and other healthcare consumers receive the quality care they deserve. HMS’ subject matter leaders also help agencies streamline their workflow, manage and report data, and leverage data to improve both efficiency and care quality.

HMS is headquartered in West Virginia and has long supported community services and projects here. HMS leaders and team members devote their time, talent, and resources to improving the lives of others, and are deeply vested in aiding specific causes and populations. Read more, here.

About Healthcare Management Solutions, LLC

HMS protects vulnerable populations and veterans. We blend our unique healthcare and technology expertise to create bold yet cost-effective solutions that federal and state agencies and our private-sector partners need to make sure your loved ones get the best possible care in nursing homes and other healthcare settings, no matter where in America they live.

Share article on social media or email:

F. Hoffmann La Roche and Johnson & Johnson license patented drug-discovery platform technologies from Housey Pharma


Both Roche, based in Basel, Switzerland, and J&J’s Janssen R&D subsidiary based in Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary to gain access to its core-enabling technology for new-drug discovery and development. Both Roche and J&J have annual Research and Development spending in excess of US $10 billion.

Scientists at Housey Pharma have developed the next generation of drug-discovery technology in the

cell-based assay field. The Company’s technologies are being offered for licensure on a non-exclusive basis to other research-based pharmaceutical companies worldwide. Cell-based assay systems are research tools that use living cells to identify and refine new medicines.

According to Dr. Housey, one of the co-inventors of the technology, the platform enables the creation of

target-specific, cell-based assay systems through specific technologies in genetic engineering, biochemistry and cell-biology. It is especially well-suited to targets previously thought to be “undruggable” in the human genome. Undruggable targets is a term used in the pharmaceutical industry to refer to biomolecules for which it was previously believed to be impossible to create a medicine capable of altering the biological function of the human body in a therapeutically beneficial manner.

“Housey Pharma has developed a technology platform to create effective medicines for the undruggable targets that are found in many human diseases, such as drug-resistant cancers, diabetes, neurodegenerative disorders such as dementia, and many other disease states,” said Dr. Housey.

The licensed drug-discovery platform technology has been awarded nine patents in the United States and dozens of other countries worldwide, with many more pending. The technology includes methods of discovering compounds that overcome drug-resistant cancers, generalized drug discovery and lead-optimization methods applicable to all human diseases, and certain compounds. The technology is particularly applicable to the discovery and development of protein kinase inhibitors useful for the treatment of drug-resistant cancers.    

“Breakthroughs in the discovery and development of new medicines are enabled through the use of this advanced technology platform,” said Dr. Housey. “We look forward to seeing innovative new medicines that benefit people around the world brought forth by our scientific colleagues at Roche and J&J. These companies have been at the forefront of innovations in medicine ranging from new treatments in oncology to COVID-19 vaccines.”

About Housey Pharma

Housey Pharma is a commercial-stage, privately held biopharmaceutical company engaged in the discovery, research, development and sale of medicines that address important, unserved medical and health needs. Housey Pharma’s products are created through the application of advanced, patented and proprietary drug discovery technologies invented by Housey Pharma. The company believes its patented technologies comprise a core-enabling technology platform that provides it with a competitive advantage for new drug discovery and creation.

Housey Pharma plans to launch a Phase 2 clinical program on one of its anti-diabetic medications in 2021. This first-in-class botanical compound targets the Insulin Receptor Substrate-2 (IRS2) pathway in human cells. IRS-2 is a protein previously considered to be an “undruggable” target. Housey Pharma has also developed the world’s first orally active compound that directly targets the same pathway that insulin uses to stimulate human cells to remove glucose (sugar) from the bloodstream. Housey Pharma’s compounds enhance insulin action in such a way that little or no insulin is needed to keep blood sugar under control. For more information, visit http://www.housey.com.

MEDIA CONTACT: Jeff Caponigro, jcap@caponigro.com, (248) 388-4981

Share article on social media or email:

USF Connect’s Tampa Bay Technology Incubator Propels Homegrown Researchers at Biotech Startup Psilera Bioscience


Psilera co-founders, Drs. Jackie Salm and Chris Witowski

We are elated to join the Incubator. This will enable us to significantly accelerate our neuromodulator pipeline and drug formulations into clinical development.

Psilera Bioscience (“Psilera”) has joined the Tampa Bay Technology Incubator, part of USF Connect (together the “Incubator”) at the University of South Florida (“USF”). The Incubator allows access to laboratories and fosters collaboration within the university to expedite developments toward commercialization.

The co-founders of Psilera, Drs. Jackie Salm and Chris Witowski, both earned their doctoral degrees in natural products chemistry from USF and now call the university home for their new biotechnology startup specializing in the clinical development of psychedelic analogues.

“As USF alumni, it is exciting for us to have the opportunity to work together on cutting-edge research in drug discovery and neurological health,” said Dr. Salm, CSO of Psilera. “It’s the ideal setting to maximize our research capabilities by utilizing state-of-the-art facilities and instrumentation.”

A research powerhouse, USF has received ‘Preeminent’ status ranking among the highest in the nation for academic research funding and in the top 10 annually with awarded patents. The university includes several multi-disciplinary centers for excellence and boasts unrivaled core facilities like the Chemical Purification and Screening laboratory to advance pioneering research. Neuroscience remains a primary focus of the university that includes leading researchers in mood, addiction, and cognitive disorders within Byrd Alzheimer’s Center and Research Institute. The Incubator hosts several biotechnology companies and is expanding with construction of new facilities already underway within USF Research Park.

Psilera will engage research faculty and university talent pools while receiving mentorship in relation to business objectives and milestones as part of the Incubator. “We welcome Psilera as we continue to support exciting startup companies in achieving their goals,” said USF Connect Program Director, Shannon Pastizzo.

“We are elated to join the Incubator,” summarized Dr. Witowski, CEO of Psilera. “This will enable us to significantly accelerate our neuromodulator pipeline and drug formulations into clinical development.”

About Psilera Bioscience – Psilera Bioscience is a psychedelic-based biotechnology company developing its proprietary neuromodulator pipeline to target central nervous system disorders. Psilera leverages research strengths with executives from the pharmaceutical and cannabis industries to repurpose psychoactive natural products as building blocks for next generation therapies to improve mental health.

Share article on social media or email:

DSS, Inc. Secures Patent for Automatic Generation of Patient Presence for Health-Related Data Management Systems


News Image

“Enhanced health data interoperability is critical for providing the best quality of care possible for patients,” said Mark Byers, president and CEO of DSS. “This patent reinforces DSS’ legacy of being a trusted provider of the most innovative health technology solutions.”

Document Storage Systems, Inc. (DSS, Inc.), a leading provider of health information technology (HIT) solutions for federal, private and public healthcare organizations, today announced the Patent Application Publication was granted to by the U.S. Patent Office for U.S. Patent number 10,607,727 entitled AUTOMATIC GENERATION OF PATIENT PRESENCE FOR HEALTH-RELATED DATA MANAGEMENT SYSTEMS.

With the management of electronic healthcare records sweeping the industry, the patent is directed to health record management systems, and how users and healthcare providers can access and interact with these systems.

This patent protects the DSS technology that allows patients, healthcare providers and facilities to transmit patient health related data to a health record management system in a secure and efficient manner.

The patented system also allows for any healthcare entity to securely submit health related data for any patient and be automatically registered with the system. Therefore, patients are no longer required to access multiple different health record management systems due to their healthcare providers being registered with different systems.

“Enhanced health data interoperability is critical for providing the best quality of care possible for patients,” said Mark Byers, president and CEO of DSS. “This patent reinforces DSS’ legacy of being a trusted provider of the most innovative health technology solutions.”

DSS Incorporated has other patents pending.

About Document Storage Systems, Inc. (DSS, Inc.)

With over 25 years of experience, DSS knows what works. We are a health information software development and systems integration company, providing services and solutions used daily by thousands of clinicians and administrative staff nationwide, to reduce costs, streamline workflows and improve patient care. For more information about DSS, visit http://www.dssinc.com.

Share article on social media or email: